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Abstract
Objective: Transient expression of therapeutic genes within lung allografts may modulate the pathological processes following allotrans-
plantation. Whilst ef®cient gene transfer to lungs has been reported with viral vectors, their usefulness is limited on the grounds of safety.
Since non-viral systems overcome many of these safety issues, our studies were designed to evaluate the ef®ciency of several non-viral gene
delivery vectors for in vivo transfer of plasmid DNA to rat lungs via the airways. Methods: Fischer rats (230±260 g) underwent a
thoracotomy, right main bronchus occlusion and instillation of 300 mg naked or complexed DNA (pCIluci, luciferase gene/CMV promoter)
to the left lung followed by ventilation for 10 min. Rats were divided into ®ve treatment groups (n  5): (1) Glucose, (2) Naked DNA, (3)
Linear polyethylenimine (PEI), (4) Branched PEI, (5) Lipid GL-67/DOPE and (6) DOTAP/cholesterol. Animals were sacri®ced 24 h after
gene delivery for measurement of reporter gene activity and gas exchange of the left lung. Results: Linear PEI was the most ef®cient gene
delivery vector and was signi®cantly better than DOTAP/cholesterol (P  0:00002) and naked DNA (P  0:004). All gene delivery vectors
impaired function of the transfected left lung compared with DNA alone. Of all the gene delivery vectors tested, lipid GL-67/DOPE exerted
the least effect on lung function whilst DOTAP/cholesterol mediated the most adverse effect. Conclusion: Linear PEI was the most ef®cient
vector for gene delivery to rat lungs in our experimental setting although it mediated a moderate impairment in lung function. Further studies
are needed to evaluate whether this effect is transient. q 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Gene transfer to allografts either prior to or at the time of
organ procurement offers a unique opportunity to transfer
therapeutic genes that may modulate the processes of
ischaemia reperfusion injury and host immune responses
[1]. With this treatment modality, it should be possible to
target the graft tissue as opposed to conventional regimes
where drug is administered systemically. The aim of gene
therapy is to deliver therapeutic genes to the nucleus of the
appropriate target cells where expression should be suf®-
cient to achieve a biological response. The availability of
ef®cient gene delivery systems is the limiting factor that has
so far hampered progress and vectors with acceptable side
effect pro®les have to be identi®ed. With speci®c reference
to the lungs, successful transduction has been reported with
replication-incompetent viruses such as adeno- [2], retro-
[3], adeno-associated [4] and lentivirus [5]. The main
advantage offered so far by viruses is their higher ef®ciency
of transduction of eukaryotic cells. Their use, however,
raises several safety concerns, which includes the elicitation
of host immune responses, induction of oncogenic effects
and recombination with wild type virus to yield replication
competent virus.
An alternative approach for gene therapy utilises plasmid
DNA. With few exceptions such as muscle and to a lesser
extent lung, many organs in vivo show limited ability to
express transgenes following administration of naked
DNA. The formation of electrostatic complexes between
plasmid DNA and cationic polymers (polyplex) [6] or lipo-
somes (lipoplex) [7] improves this low transfection ef®-
ciency. Such non-viral gene delivery systems overcome
many of the problems associated with the use of viruses
with the added advantages that they are relatively easy to
produce in large quantities and are potentially less toxic.
Although a number of non-viral vectors have been described
and are commercially available, the ideal system for
pulmonary gene delivery via the airways has yet to be estab-
lished. Hence, the studies described here were designed
to evaluate the ef®ciency of four non-viral vectors for plas-
mid DNA delivery to rat lungs and their effects on gas
exchange.
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2. Materials and methods
2.1. Gene transfer vectors
Linear 22 KDa PEI (Exgene 500, Euromedex, Souffel-
weyersheim, France) was purchased as a 1 M aqueous stock
solution. Branched 25 KDa PEI (Sigma-Aldrich, Schnell-
dorf, Germany) was prepared as a 0.1 M aqueous solution as
previously described [8]. N-[1-(2,3-dioleoyloxy)propyl]-
N,N,N-trimethylammonium methylsulphate (DOTAP)/
cholesterol was obtained from Dr Smyth-Templeton
(Baylor college of Medicine, Houston, TX) as a 20 mM
aqueous solution. Lipid GL-67:DOPE 2:1 (kindly provided
by Genzyme, Framingham, MA, USA) was obtained as a
dried lipid ®lm and re-constituted as a 2 mM aqueous solu-
tion immediately prior to use.
2.2. Plasmid DNA
Plasmid, pCIluci (kindly provided by Oliver Schwicker-
ath, Institute of Child Health, London) contains the lucifer-
ase reporter gene under the control of the cytomegalovirus
(CMV) inducer/enhancer promoter element. The plasmid
was propagated in E. coli XL-1 blue, isolated by the alkaline
lysis method and puri®ed by anion exchange chromato-
graphy (Hybaid, Ashford, UK). The quality and quantity
of puri®ed plasmid DNA was assessed by absorption
measurements at 260 and 280 nm as well as electrophoresis
on a 1 w/v percent agarose gel.
2.3. Preparation of transfection complexes
All complexes between plasmid DNA and polymer/lipo-
some were prepared in 5% dextrose with the exception of
GL-67/DOPE/DNA lipoplexes, which were prepared in
water. The appropriate quantity of liposome/polymer was
diluted to a volume of 250 ml and 300 mg of plasmid DNA
was separately diluted to the same volume. The diluted
liposome/polymer solution was then added to the DNA
solution followed by mixing with a pipette tip. After mixing,
complexes were incubated for either 10 min (polyplex) or
30 min (lipoplex) before administration to rats. For complex
preparation, the following amounts of vector were used per
300 mg DNA: 4.5 ml linear PEI; 0.227 mmol GL-67/DOPE;
46 ml branched PEI; 60 ml DOTAP/cholesterol.
2.4. Animals
Inbred male F344 rats with a weight range of 230±260 g
were used. All animals received humane care in compliance
with the European Convention of Animal Care. The study
protocol was approved by the local animal study committee.
2.5. Gene administration
The recipient was anaesthetized by breathing halothane in
a glass chamber, intubated with a 14-gauge catheter, and
anaesthesia was maintained with halothane 2±2.5%. A
right thoracotomy was performed and the right hilar region
dissected. The right main bronchus was occluded with a
removable micro-vascular clip. A solution of 500 ml
(containing 300 mg plasmid DNA alone or complexed
with the gene delivery vector) was instilled to the left
lung via the tube followed by isolated left lung ventilation
for 10 min. The microvascular clip on the right main
bronchus was removed, a chest tube was inserted and the
thoracotomy was closed. The chest tube was removed after
restoration of suf®cient spontaneous breathing a few
minutes after extubation.
2.6. Study groups
Rats were divided into ®ve groups (n  5). The groups
were: (1) Naked DNA; (2) Linear PEI/DNA; (3) Branched
PEI/DNA; (4) GL-67/DOPE/DNA and (5) DOTAP/choles-
terol/DNA. Two rats in the DOTAP/cholesterol/DNA died
shortly after instillation and hence n  3.
2.7. Blood gas analysis
Twenty-four hours after DNA administration, the animal
was anaesthetized by intraperitoneal administration of
pentobarbital (50 mg/kg body weight) and heparinized
(500 I.U./kg body weight.). The animal was ventilated
with 100% O2, a positive end-expiratoric pressure (PEEP)
of 5 mm H2O, a frequency of 100/min and a tidal volume of
8 ml/kg body weight by a Harvard rodent ventilator
(Harvard Apparatus, South Natick, MA) via a tracheotomy.
For functional assessment of the transfected left lung, the
right hilum was dissected and the right pulmonary artery
and the right main bronchus were occluded with microvas-
cular clips. Five minutes after occlusion, an arterial blood
gas sample was collected from the thoracic aorta for func-
tional assessment of the transfected lung only and measured
on an automatic blood gas analyser (ABL500, Radiometer
GmhB, Thalwil, Switzerland). The lungs were then perfused
with 20 ml 0.9% saline at a pressure of 20 cm H2O via the
pulmonary vein and divided into upper, middle and lower
portions. Samples of the lung were snap frozen in liquid
nitrogen and stored at 2808C until analysis.
2.8. Luciferase assay
For luciferase assay, lung tissue was weighed and homo-
genised (Polytron, Littau, Switzerland) in 5 £ ice-cold repor-
ter lysis buffer (Promega, Zurich, Switzerland) for 1 min,
freeze thawed three times and centrifuged at 14 000 £ g for
15 min. The luciferase activity in 20 ml of lysate was
measured on a luminometer (Mediators PhL, Mediators
Diagnostika, Vienna, Austria) programmed to inject 100 ml
of luciferase assay buffer (Promega). Integrated light units
were collected over 10 s. Relative light units (RLU) were
normalised to protein content in each sample (Biorad Dc
protein assay kit, Biorad, CH) using bovine serum albumin
as a standard. All data are expressed as RLU/mg protein.
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Since luciferase activity was variable between upper, middle
and lower sections of the lungs and the region of maximal
expression varied between rats, the data represents the overall
mean luciferase activity in the left lungs.
2.9. Statistics
Since data were not normally distributed, logarithmic
transformation was performed prior to analysis of variance
(ANOVA) with post-hoc comparison (ScheffeÂ test). The
STATISTICA 5.1 software (StatSoft, Tulsa, Oklahoma)
was used. A P-value of less than 0.05 was considered signif-
icant.
3. Results
3.1. Arterial blood gas analysis
The function of the left lung was analysed 24 h after gene
administration by arterial blood gas measurement (PaO2)
after ventilation for 5 min on 100% oxygen (Table 1 and
Fig. 1). PaO2 was reduced in all rats that received lipoplex or
polyplex compared to treatment with naked DNA (median
PaO2 454 mmHg). PaO2 was signi®cantly lower after treat-
ment with linear PEI (median PaO2 116 mmHg,
P  0:0018) and DOTAP/cholesterol (median PaO2 29
mmHg, P  0:0001) compared to naked DNA. Lipid GL-
67/DOPE exerted the least effects on lung function of all the
gene delivery vectors tested (median PaO2 367 mmHg).
3.2. Luciferase expression in transfected lungs
To assess the ef®ciency of transfection mediated by the
various gene delivery vectors, luciferase activity was
measured 24 h after plasmid DNA delivery and all data
were standardised to total protein. There was no luciferase
activity observed in the right lungs or trachea. A trend
towards superior transfection activity was observed with
linear PEI (median 1432 RLU/mg, Table 1 and Fig. 2),
however, within this group there was considerable variabil-
ity and statistical signi®cance was only achieved when
compared with DOTAP/cholesterol (median 16 RLU/mg,
P  0:0002) and naked DNA (median 102 RLU/mg,
P  0:0042). Luciferase activity following transfection
with branched PEI (median 537 RLU/mg) was lower than
achieved with linear PEI, however the distribution range
between animals was smaller. Transfection activity with
GL-67/DOPE was also lower than linear PEI, but due to
the intra-group variability statistical signi®cance was not
reached (median 232 RLU/mg, P  0:056).
4. Discussion
This study was designed to compare the relative ability of
four non-viral gene delivery vectors to mediate plasmid
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Table 1
Arterial blood gas (PaO2) and luciferase activity (RLU/mg) in the left
transfected lung 24 h after gene administrationa
Gene delivery system PaO2 (mmHg) Luciferase activity (RLU/mg)
Glucose 433 (367±484) 0
Naked DNA 454 (311±465) 102 (43±287)b
Linear PEI 116 (82±253)c 1432 (999±2253)
Branched PEI 236 (145±288) 537 (406±646)
GL67 367 (220±412) 232 (58±1372)
DOTAP-cholesterol 29 (28±33)d 16 (16±40)e
a Data represent the median and range.
b P  0:0042 compared to the linear PEI treatment group.
c P  0:0018 compared to the naked DNA treatment group.
d P  0:0001 compared to the naked DNA treatment group.
e P  0:0002 compared to the linear PEI treatment group.
Fig. 1. Gas exchange of the left transfected lung after exclusion of the right
lung 24 h after instillation of naked DNA or complexes formed with linear
PEI (L-PEI), branched PEI (B-PEI), GL-67/DOPE and DOTAP/choles-
terol. PaO2 was measured after clamping of the right main bronchus and
ventilating for 5 min with FiO2 1.0. Each data point represents a single
animal. *P  0:0018, **P  0:0001 vs. group I.
Fig. 2. Transfection activity in left lungs of rats after administration of
naked DNA or complexes formed with linear PEI, branched PEI, GL-67/
DOPE and DOTAP/cholesterol. Each data point represents a single animal
and results show luciferase activity standardised to total protein (RLU/mg).
*P  0:0042, **P  0:0002 vs. group II.
DNA transfer to rat lungs by instillation through the airways
relative to transfection with naked DNA.
Consistent with previous reports [9], reporter gene activ-
ity was observed after the instillation of naked DNA (Fig.
2). In order to enhance transgene expression, plasmid DNA
was complexed with gene delivery vectors that have
previously shown promise for pulmonary gene transfer.
Non-viral gene delivery vectors serve multiple purposes.
Firstly, they interact through electrostatic forces with nega-
tively charged phosphate residues on the DNA backbone
thereby neutralising the charge. Charge neutralisation
results in collapse of the extended structure of plasmid
DNA into small discrete particles amenable for endocytosis.
In general, complexation of plasmid DNA with cationic
polymers results in the formation of smaller particles than
with liposomes, a factor that may in¯uence transfection
ef®ciency. For instance, PEI/DNA complexes are reported
to be 50±60 nm when prepared in a non-ionic solution such
as glucose [10] whilst DOTAP/DNA complexes are in
excess of 250 nm [11]. Secondly, when DNA lipoplexes
or polyplexes are formulated with an excess positive charge,
interactions with anionic residues on biological membranes
are facilitated. Finally, cationic gene delivery systems have
been shown to protect plasmid DNA from enzymatic degra-
dation and physical shear [12].
The gene delivery vectors that were evaluated in this
study have been well characterised however, a direct
comparison has not been established. Lipid GL-67/DOPE
is a cholesterol-based cationic lipid, formulated with the
fusogenic helper lipid, dioleoylphosphotidylethanolamine
(DOPE). This liposome preparation was reported to be the
least toxic and most ef®cient in a series of compounds
developed for pulmonary gene transfer to mice lung [13].
DOTAP is a biodegradable monovalent cationic lipid
originally shown to be effective in vitro for the transfection
of various mammalian cell lines. The in vivo ef®ciency of
DOTAP was later described by McLachlan et al. [14] after
airway administration to mice lungs. It was subsequently
shown that transfection activity in pulmonary tissue after
intravenous administration could be enhanced by co-formu-
lation of DOTAP with cholesterol [15]. Further experience
with DOTAP extends to humans where it has been used to
deliver the cystic ®brosis trans-membrane regulator gene to
the airways of cystic ®brosis patients [16]. Polyethyleni-
mine, ®rstly described in 1995 [8] for the transfection of
mammalian cells, was later shown to be effective for trans-
fection of various tissues including lungs [17], liver [18] and
brain [10]. PEI has the highest cationic charge density of
any known organic polymeric macromolecules and its
superior transfection activity is believed to originate from
its ability to act as a `proton sponge' under acidic condi-
tions. Essentially, the protonation pro®le for PEI increases
from 20 to 45% between pH 7 and 5; conditions which
would be encountered within the endosome. This buffering
is believed to prevent the degradation of internalised plas-
mid DNA. In addition to its endosomal buffering capabil-
ities, PEI has recently been shown to facilitate transfer of
plasmid DNA across the nuclear membrane, thereby over-
coming one of the fundamental barriers to successful gene
delivery [19]. This is an advantage over the use of liposomes
that are retained within endosomal compartments for
considerable periods of time following cellular uptake [20].
With the exception of DOTAP/cholesterol, complexation
of plasmid DNA with cationic liposomes and polymers
enhanced luciferase activity in lungs (Fig. 2). Linear PEI
in particular showed good transfection activity, however,
due to the large intra-group variability, statistical signi®-
cance was only achieved when compared with naked
DNA and DOTAP/cholesterol/DNA. The reasons for the
large intra-group variability are presently unclear. However,
one factor, which may have contributed to this effect, relates
to the fact that lipoplexes/polyplexes were prepared indivi-
dually for each animal in order to minimise aggregation that
can occur after prolonged storage. Further studies will aim
to identify ways of minimising this variability by optimising
the protocols for complex preparation and administration
technique. With reference to the two types of PEI tested, a
trend towards better transfection activity was observed with
linear PEI compared to branched PEI. It is not clear whether
this is due to the use of the linear form of the polymer or a
result of the slightly lower molecular weight of linear PEI.
Branched PEI did show the advantage of achieving better
reproducibility in transfection.
DOTAP/cholesterol has been shown to be ef®cient for
pulmonary gene transfer [15] by intravenous administration
although in our hands it was the most toxic vector. In addi-
tion to the different administration route used in our studies,
our protocol involved formulation of complexes at a nitro-
gen/phosphate ratio of 2 and we initially speculated that this
partly accounted for the observed toxicity. Formulating
complexes at a net neutral charge, however, did not affect
toxicity (data not shown). It is possible that pulmonary toxi-
city is reduced if these complexes are administered via the
systemic circulation due to dilution, however, this adminis-
tration route was not an option in this setting as we intended
to avoid transgene expression in secondary organs.
The ultimate goal with gene therapy in organ transplanta-
tion is to transfer genes that express immunomodulatory and
protective genes to allografts prior to explantation such that
they are present at the time of reperfusion. It is therefore
important to establish transfection procedures that are not
harmful to the graft. Indeed, in rats treated with naked DNA,
we observed that 24 h after gene administration, lung func-
tion was comparable to that of untreated controls. In
contrast, in all animals treated with lipoplexes or poly-
plexes, impairment in lung function was observed, with
DOTAP/cholesterol showing the most toxic effects (Fig.
1). We speculate that the low luciferase activity in
DOTAP/cholesterol treated rats was as a direct consequence
of impaired lung compliance.
Non-viral gene transfer correlated in our hands with a
substantial impairment of lung function. This ®nding
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demonstrates a limitation of the so far known non-viral
vectors and reinforces the need for careful assessment of
their toxicity. Further studies are needed to establish
whether the observed impairment in lung function is tran-
sient and to identify other less toxic and ef®cient non-viral
gene delivery vectors.
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